In kidney-related studies, it was found that the expression of IRAK1 in the peripheral blood of patients with lupus nephritis was increased, and the use of IRAK1 inhibitors could alleviate kidney damage in lupus mice (35). This evidence concerns the gene IRAK1 and systemic lupus erythematosus.